Jerusalem Pharmaceuticals Co. Ltd. (PEX: JPH)

Jerusalem Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	37.5	39.65	46.14	46.23	36.4	34.09
Revenue Growth (YoY)	-14.71%	-14.06%	-0.18%	27.00%	6.77%	10.67%
Cost of Revenue	17.46	18.07	23	23.44	20.28	18.23
Gross Profit	20.04	21.59	23.14	22.79	16.12	15.86
Selling, General & Admin	10.28	10.54	12.23	12.57	10.4	10.02
Research & Development	1.2	1.41	1.73	1.74	1.38	0.8
Other Operating Expenses	0.55	-0.15	-0.26	0.07	0.11	-0.14
Operating Expenses	13.02	12.61	14.33	14.81	12.11	10.67
Operating Income	7.02	8.98	8.81	7.98	4.01	5.19
Interest Expense	-0.09	-0.04	-0.06	-0.06	-0.06	-0.06
Interest & Investment Income	0.18	0.18	0.03	0.02	0.05	-
Earnings From Equity Investments	-	-	-	-0	0.02	0.08
Currency Exchange Gain (Loss)	-0.08	-0.08	0.36	-0.21	-0.07	-0.18
Other Non Operating Income (Expenses)	-0.19	-0.19	-0.14	-0.16	-0.22	-0.19
EBT Excluding Unusual Items	6.85	8.86	9	7.57	3.74	4.85
Gain (Loss) on Sale of Investments	-0.15	-0.15	0	0	0	0
Gain (Loss) on Sale of Assets	0.11	0.11	-	0.01	-	-
Other Unusual Items	-	-	0.03	0.04	0	-
Pretax Income	6.81	8.82	9.03	7.62	3.74	5.03
Income Tax Expense	1.54	1.81	1.82	1.4	0.07	0.02
Earnings From Continuing Operations	5.27	7.01	7.21	6.22	3.67	5.01
Earnings From Discontinued Operations	-	-	-0.21	-	-	-
Net Income to Company	5.27	7.01	7	6.22	3.67	5.01
Minority Interest in Earnings	-0.06	-0.05	0.17	0.38	0.06	0.34
Net Income	5.21	6.96	7.17	6.6	3.73	5.35
Net Income to Common	5.21	6.96	7.17	6.6	3.73	5.35
Net Income Growth	-32.41%	-3.02%	8.73%	77.12%	-30.39%	-2.67%
Shares Outstanding (Basic)	18	18	18	18	18	18
Shares Outstanding (Diluted)	18	18	18	18	18	18
EPS (Basic)	0.29	0.39	0.40	0.37	0.21	0.30
EPS (Diluted)	0.29	0.39	0.40	0.37	0.21	0.30
EPS Growth	-32.41%	-3.02%	8.73%	77.12%	-30.39%	-2.67%
Free Cash Flow	4.57	7.84	16.32	3.86	0.45	0.81
Free Cash Flow Per Share	0.25	0.44	0.91	0.21	0.02	0.04
Dividend Per Share	0.100	0.100	0.150	0.120	0.080	0.100
Dividend Growth	-33.33%	-33.33%	25.00%	50.00%	-20.00%	0%
Gross Margin	53.44%	54.44%	50.15%	49.30%	44.28%	46.53%
Operating Margin	18.72%	22.65%	19.09%	17.25%	11.02%	15.24%
Profit Margin	13.89%	17.54%	15.55%	14.27%	10.23%	15.70%
Free Cash Flow Margin	12.17%	19.77%	35.37%	8.35%	1.23%	2.37%
EBITDA	8.14	10.17	10.53	9.94	5.95	6.87
EBITDA Margin	21.70%	25.65%	22.83%	21.49%	16.34%	20.16%
D&A For EBITDA	1.12	1.19	1.73	1.96	1.93	1.68
EBIT	7.02	8.98	8.81	7.98	4.01	5.19
EBIT Margin	18.72%	22.65%	19.09%	17.25%	11.02%	15.24%
Effective Tax Rate	22.59%	20.55%	20.18%	18.42%	1.96%	0.34%
Advertising Expenses	-	0.01	0.06	0.05	0.04	0.15

Source: S&P Capital IQ. Standard template. Financial Sources.